Junbo Ge

Junbo Ge

China

Statement of motivation

Hello, I am Dr. Junbo Ge from Shanghai, China. I run for the President-Elect 2025-26 of the World Heart Federation.

After nearly 10 year’s study and work in Germany, I have built close friendship with international colleagues and became members of many international cardiovascular societies. I believe I am able to work with you all to achieve our goal.

First of all, as a first line cardiologist, I have witnessed the spectrum transition of the patients from rheumatic heart diseases to ischemic heart diseases in China. The outbreak of diabetes, dyslipidemia which led to the fast increase of systematic vascular atherosclerotic diseases in the past decades.  I believe these experiences would be helpful to the lower-and-middle income countries not to repeat the same disease track.

In the past 20 years, I have led national and international cardiovascular organizations and gathered plenty experiences. I have implemented the “green channel” concept for acute myocardial infarction which has been developed to the China’s chest pain network covering more than 5000 hospitals throughout China and rescued millions of high risk patients. In addition, our data showed that air pollution and environmental temperature change would affect the occurrence of heart attacks.

After almost 10 years’ service and contribution to WHF, I have found that I have the passion to work for the WHF in the next years. WHF put a high attention on the lower-and-middle income countries to reduce the cardiovascular burden which is what I have worked and will work for.

If I am able to be assigned, I would work together with members of the WHF to dedicate our efforts on improving global cardiovascular health.

Cardiovascular Health for Everyone.

Your support is highly appreciated!

Thank you!

Biography

Junbo Ge, born in 1962, received his doctorate degree in University Mainz, Germany in 1993. In 1995, he was promoted as the director of the Intravascular Ultrasound lab of the Department of Cardiology, University Essen, Germany. In 1999, he was invited to Shanghai, China and working as co-director of the Department of Cardiology of Zhongshan Hospital, Fudan University.

Prof. Ge is now Academician of Chinese Academy of Sciences; Director of the Department of Cardiology, Zhongshan Hospital, Fudan University; Chairman of Shanghai Cardiovascular Clinical Center and Chairman of Shanghai Institute of Cardiovascular Diseases; Dean of Institutes of Biomedical Sciences, Fudan University; Chairman of National Clinical Research Center for Interventional Medicine.

He is also the President of Chinese College of Cardiovascular Physicians, President of Chinese Cardiovascular Association, Past President of Chinese Society of Cardiology (2015-2018); International Governor of American College of Cardiology, Board Member of World Heart Federation, Daniel L. Macken Visiting Professor of Columbia University.

Dr. Ge is devoted to academics, not only has made great achievements in clinical and scientific research, but also has rich experience in composing textbooks and operating journals. He has been responsible for over 120 international and national scientific research projects.  He has published more than 639 papers as first author or corresponding author  in international peer reviewed journals. He has edited and co-edited 25 monographs and textbooks.

He is also the Deputy editor of International Journal of Cardiology, Deputy Editor of Herz, Deputy Editor of Heart，Editor-in-Chief of Cardiology Plus, Chief Editor of Textbook of Internal Medicine (8th and 9th editions), Chief Editor of Practical Internal Medicine (15th and 16th edition) and international editorial board of many international academic journals.

He has long been engaged in cardiovascular disease research and interventional cardiology. In 2005, he created the retrograde wire technique and transmitted live demonstration to TCT for the first time which has been becoming the routine approach for coronary chronic total occlusion. He then modified the technique with the named AGT (active greeting technique) which made the intervention procedure easier and time saving.  These techniques greatly improved the success rate of coronary chronic total occlusion. He leds his group developed and patented many innovative devices including biodegradable polymer DES, As₂O₃ drug coated stent, transapical mitral valve repair device ValveClamp. In 1999, he implemented the “green channel” treatment concept of acute myocardial infarction which has been developed to the China’s chest pain treatment system, China Chest Pain Center, which covers about more than 4000 hospitals throughout China and rescued millions of emergent patients.

He has done hundreds of live transmissions of coronary intervention to most of the international meetings such as TCT, Euro-PCR, CCT, and national meetings. He has been invited to more than 20 countries including Indonesia, Kazakhstan, Kyrgyzstan, Bangladesh, India, Japan, Korean, Singapore, South Africa, India, and the Philippines etc. to do live demonstrations of coronary intervention. Under his leadership, CCA has established close relationship with most of the international cardiovascular societies and 52 well-known medical centers.